Research interests include Lung Cancer Treatments and Mutations, HER2/EGFR in Cancer Research, Lung Cancer Research Studies, and RNA modifications and cancer.
<i>HER2</i> Amplification: A Potential Mechanism of Acquired Resistance to EGFR Inhibition in <i>EGFR</i> -Mutant Lung Cancers That Lack the Second-Site <i>EGFR</i> T790M Mutation
Cancer Discovery2012cited by 724position: firstdoi